In this study, we propose to investigate in a phase II trial the therapeutic efficacy of tiazofurin in the blast crisis phase of chronic myelogenous leukemia. Blast crisis of chronic myelogenous leukemia is the terminal phase of 60-75% of patient with CML. BC is defined as the presence of 30% or more blasts in the peripheral blood or bone marrow and is often heralded by the development of extramedullary disease, bone marrow failure and other complications.
Showing the most recent 10 out of 782 publications